Taro Shimazaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Taro Shimazaki has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Satoshi Kawaguchi
Department of Surgery II, Tokyo Medical University, Tokyo, Japan
2 shared publicationsShin Ishimaru
Department of Surgery II, Tokyo Medical University, Tokyo, Japan
2 shared publicationsYoshihiko Yokoi
Department of Surgery II, Tokyo Medical University, Tokyo, Japan
2 shared publicationsYoshiko Watanabe
Department of Surgery II, Tokyo Medical University, Tokyo, Japan
2 shared publicationsNaozumi Saiki
Department of Surgery II, Tokyo Medical University, Tokyo, Japan
1 shared publicationSusumu Makimura
Department of Surgery II, Tokyo Medical University, Tokyo, Japan
1 shared publication
Latest Publications
- 1 October 2006
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 40 (5) , 374-382
Evaluation of Thrombogenicity by Indium-111 Platelet Scintigraphy in Endografting for Abdominal Aortic Aneurysms
Obstruction of the endograft limb by thrombosis has often been reported and may cause fatal complications such as leg necrosis or myonephropathic metabolic syndrome. The purpose of this study was to evaluate endograft antithrombogenicity by indium-111 platelet scintigraphy. Seventeen patients with abdominal aortic aneurysms were treated by endografting. Thirteen patients were treated with conventional open surgery using an artificial graft. The endograft was constructed from a self-expanding Z-shaped stent and woven polyester fabric. Autologous platelets labeled with indium-111 were injected at 2 weeks postoperatively. At 24 hours and 72 hours postinjection, the ratio of scintillation count of the endograft or graft to that of the native artery was calculated to assess platelet deposition. The normalization ratio was calculated as follows: (scintillation count per pixel of endograft or graft/circumference)/(scintillation count per pixel of the native femoral artery). Platelet factor 4 and beta-thromboglobulin were measured to evaluate the systemic platelets activity at 2 weeks postoperatively. There was no significant difference in platelet counts or labeling efficiency between the groups. The ratio was significantly higher in the endografting group than in the open surgery group at 72 hours postinjection (2.5-0.7 vs 3.9-1.1, P<.001). There was no significant difference in platelet factor 4 and beta-thromboglobulin between the groups. Although there was no difference in systemic platelet activity, endografting was associated with lower antithrombogenicity. It remains unclear whether lower antithrombogenicity causes thromboembolism as a complication of the procedure. The authors recommend the administration of antiplatelet drugs to prevent endograft obstruction in patients with very narrow iliac arteries.
- 1 October 2006
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 40 (5) , 374-382
Evaluation of Thrombogenicity by Indium-111 Platelet Scintigraphy in Endografting for Abdominal Aortic Aneurysms
Obstruction of the endograft limb by thrombosis has often been reported and may cause fatal complications such as leg necrosis or myonephropathic metabolic syndrome. The purpose of this study was to evaluate endograft antithrombogenicity by indium-111 platelet scintigraphy. Seventeen patients with abdominal aortic aneurysms were treated by endografting. Thirteen patients were treated with conventional open surgery using an artificial graft. The endograft was constructed from a self-expanding Z-shaped stent and woven polyester fabric. Autologous platelets labeled with indium-111 were injected at 2 weeks postoperatively. At 24 hours and 72 hours postinjection, the ratio of scintillation count of the endograft or graft to that of the native artery was calculated to assess platelet deposition. The normalization ratio was calculated as follows: (scintillation count per pixel of endograft or graft/circumference)/(scintillation count per pixel of the native femoral artery). Platelet factor 4 and beta-thromboglobulin were measured to evaluate the systemic platelets activity at 2 weeks postoperatively. There was no significant difference in platelet counts or labeling efficiency between the groups. The ratio was significantly higher in the endografting group than in the open surgery group at 72 hours postinjection (2.5-0.7 vs 3.9-1.1, P<.001). There was no significant difference in platelet factor 4 and beta-thromboglobulin between the groups. Although there was no difference in systemic platelet activity, endografting was associated with lower antithrombogenicity. It remains unclear whether lower antithrombogenicity causes thromboembolism as a complication of the procedure. The authors recommend the administration of antiplatelet drugs to prevent endograft obstruction in patients with very narrow iliac arteries.
- 30 June 2003
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 37 (6) , 1213-1218
Blood coagulation and fibrinolytic response after endovascular stent grafting of thoracic aorta
- 30 June 2003
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 37 (6) , 1213-1218
Blood coagulation and fibrinolytic response after endovascular stent grafting of thoracic aorta